With this notice, Frontiers states its awareness of concerns regarding the METRICS study described in this article. This expression of concern has been posted while Frontiers investigates the allegations. The situation will be updated as soon as the investigation is complete.
. 2023 Jul 31;14:1264737. doi: 10.3389/fphar.2023.1264737
Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)
Frontiers Editorial Office*
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉
*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org
Received 2023 Jul 21; Accepted 2023 Jul 21; Collection date 2023.
Copyright © 2023 Frontiers Editorial Office.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
PMCID: PMC10426282 PMID: 37587985
This is an expression of concern about the following article: "A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)" in volume 10, 681.